“Check what box?” you may ask. Let me explain — without getting too hung up on a paraphrase of Shakespeare’s famous question.
In the wake of the 2014 AER Conference last December, I have spent considerable time reflecting on the current regulatory framework governing human subjects research. (Yes, I do have a life, but I am a Certified IRB Professional [CIP®], so matters like these interest me.) In the United States, federal regulations require that all research on human subjects be reviewed and approved by an institutional review board (IRB). IRBs have the authority to approve, disapprove, or require modifications to research protocols, which may be why many researchers consider submitting a proposal to the IRB akin to suffering “the slings and arrows of outrageous Fortune.” [There’s that Shakespeare again.]
One of the key elements underpinning a high-functioning IRB is its autonomy to make its determinations independent of other institutional goals or activities. This is an IRB prerogative that may cause consternation for some individual researchers and relief for others. In addition, institutions that conduct human subjects research sponsored by the federal government are required to provide written assurance to the Office of Human Research Protections (OHRP) that the research will be conducted in compliance with the regulations. Traditionally, most institutions have simplified matters by stipulating that all human subjects research conducted under its purview will comply with the federal regulations regardless of the funding source for the project. This practice has been referred to colloquially as “checking the box.”
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.